Latest Breaking News On - European respiratory society congress - Page 1 : comparemela.com

AstraZeneca announces initiation of THARROS – a Phase III clinical trial investigating the potential of BREZTRI to improve cardiopulmonary outcomes in people with COPD

THARROS is the first-ever prospective trial to investigate the potential of an inhaled triple therapy to reduce cardiopulmonary events, a key driver of mortality, in COPD First patients dosed in.

United statesNew yorkUnited kingdomFernando martinezSharon barrFormoterol fumarateEuropean respiratory society congressNational heartDivision of pulmonaryGlobal initiative on obstructive lung diseaseBlood instituteCenters for diseaseGlobal initiative for chronic obstructive lung diseaseInternational investigatorData networkHarvard medical school

Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript

Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript February 21, 2024 Pulmonx Corporation beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.39. LUNG isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]

John mckuneJason bednarPiper sandlerEuropean respiratory society congressZephyr valveAeriseal pivotal trialZephyr valvesSteve williamsonAffordable placesActually growingFourth quarterPulmonx corporationZephyr valveElaine morganForward looking statements

Demand for Sleep Care Devices Propels ResMed Growth in Q1

ResMed Inc attributed first-quarter growth to heightened demand for its sleep and respiratory care devices.

Mick farrellEuropean respiratory society congressResmed inc

Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine

Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Thomasw ferkol jrFelix ringshausenKarl donnPaul boucherMichele manionEuropean respiratory society congressEuropean respiratory society international congressCystic fibrosis foundationParion sciences announces publication of phaseDrug developmentParion sciencesCiliary dyskinesia foundationParion sciences incNational institutes of healthSciences announces publicationLancet respiratory

Smart Inhalers Market Size, Share & Trends Analysis Report By Type, By Indication, By Distribution Channel, By End-use, By Region And Segment Forecasts, 2022

/PRNewswire/ Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma,.

United statesAsia pacificAptar pharmaEuropean respiratory society congressInhalers market sizeTrends analysis report by typeDry powdered inhalersMetered dose inhalersDistribution channelSegment forecastsHerotracker senseAdherium smartNorth america